KIR and HLA genotypes influence clinical outcome in multiple myeloma patients treated with SAR650984 (anti-CD38) in combination with lenalidomide and dexamethasone

Category Primary study
JournalBlood
Year 2014
This article has no abstract
Epistemonikos ID: cca03e0b9bb7fa06b51bf7493fc5bfb91a8a7b84
First added on: Feb 06, 2025